Bronchiolitis obliterans syndrome (BOS) remains the most common late-onset, noninfectious pulmonary complication after allogeneic haematopoietic stem cell transplant (HSCT) and an area of need for both prevention and treatment. Professor Anne Bergeron, from the Hôpital Saint-Louis in Paris, told the recent ERS Congress in Paris that BOS represented 40% of the lung complications in a ...
Lung complications tough to treat post-HSCT
By Mardi Chapman
9 Oct 2018